+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
In Vivo CRO Market - Global Forecast 2026-2032- Product Image
In Vivo CRO Market - Global Forecast 2026-2032- Product Image
New

In Vivo CRO Market - Global Forecast 2026-2032

  • PDF Icon

    Report

  • 192 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 5666068
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The in vivo contract research organization (CRO) sector is undergoing transformation as senior decision-makers face increasing scientific and operational complexity in preclinical development. As client demands for scientific depth, data transparency, and agility intensify across biopharma and device domains, excellence in in vivo CRO performance has become central to translational success.

Market Snapshot: In Vivo CRO Market Growth

The In Vivo CRO Market grew from USD 6.58 billion in 2025 to USD 7.21 billion in 2026 and is projected to reach USD 12.88 billion by 2032, representing robust growth at a CAGR of 10.06%. This trajectory reflects rising demand for advanced preclinical models and increasing reliance on external partners to guide therapeutic innovation and ensure regulatory readiness.

Scope & Segmentation of the In Vivo CRO Market

This report provides a comprehensive view of the in vivo contract research landscape, assessing how specialized scientific services, operational imperatives, and regional dynamics drive competitive differentiation. The following segmentation framework supports clear market understanding and informed sourcing decisions:

  • Model Type: Rodent vs non-rodent studies, each requiring tailored infrastructure and operational expertise.
  • Service Offerings: Encompassing clinical services, toxicology, consulting & strategy, laboratory operations, preclinical processes, regulatory support, and safety assessments.
  • Therapeutic Modality: Differentiation between large- and small-molecule development, impacting study design and bioanalytical methods.
  • Indication Requirements: Specific disease focus (e.g., cardiovascular, neurological, infectious, oncology, respiratory), each with distinct model and assay needs.
  • End-User Expectations: Addressing requirements of academic & research centers, regulatory bodies, medical device firms, and biopharma sponsors with varying timelines and governance protocols.
  • Regional Dynamics: Variation in operational capacity and regulatory environments across Americas, EMEA, and Asia-Pacific, influencing study execution and compliance.
  • Technology Integration: Includes automation, digital pathology, remote data management, and modality-specific biomarker platforms.

Key Takeaways for Senior Decision-Makers

  • Integrated service portfolios offered by in vivo CROs now span the spectrum from study design to translational biomarker validation, responding to the growing need for seamless program support.
  • Scientific rigor, reproducibility, and alignment with ethical frameworks (such as the 3Rs) are top priorities, driving adoption of standardized protocols and advanced quality controls.
  • Operational consolidation is increasing as industry sponsors seek single-source partners to streamline program oversight and reduce administrative burden.
  • Service provider selection increasingly hinges on demonstrated therapeutic-area experience, validated platform models, and capability for cross-regional execution.
  • Customization, including modular service bundling and alignment to sponsor workflows, enhances study validity and supports regulatory submissions on a global scale.

Tariff Impact: Navigating Sourcing and Supply Chain Disruption

Recent changes in United States tariff policy have heightened operational complexity for in vivo research organizations with international sourcing requirements. Procurement leaders and program managers are recalibrating relationships and exploring regional alternatives to maintain project continuity. Emphasis on customs expertise and regional service delivery helps mitigate disruption, with contingency planning and sensitivity analysis now integral to contract structuring.

Methodology & Data Sources

This market report integrates peer-reviewed literature, regulatory documentation, and supplier disclosures with anonymized expert interviews. Qualitative and comparative analysis inform findings, with a focus on empirical trends in reproducibility, service integration, and supply chain impacts. Throughout, the research approach emphasizes validation of operational realities as reported by experienced stakeholders.

Why This Report Matters

  • Provides a nuanced understanding of how specialization, reproducibility, and operational flexibility underpin sponsor outcomes in increasingly complex preclinical programs.
  • Enables strategic supplier selection and risk mitigation by unpacking segmentation, technology use, and regional drivers influencing in vivo research success.
  • Guides investment and procurement strategies to align internal resources and external partnerships with evolving sponsor and regulatory requirements.

Conclusion

The evolving in vivo CRO market demands heightened specialization, integrated services, and operational resilience. Stakeholders who invest in robust model platforms, quality systems, and strategic partnerships are poised to reduce translational risk and accelerate clinical progress.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. In Vivo CRO Market, by Type
8.1. Non-Rodent
8.2. Rodent
9. In Vivo CRO Market, by Service Type
9.1. Clinical Services
9.2. Consulting & Strategy
9.3. Laboratory Services
9.4. Preclinical Services
9.5. Regulatory Services
9.6. Toxicological & Safety Assessment
10. In Vivo CRO Market, by Modality
10.1. Large Molecules
10.2. Small Molecules
11. In Vivo CRO Market, by Indication
11.1. Cardiovascular Diseases
11.1.1. Coronary Artery Disease
11.1.2. Heart Failure
11.2. Infectious Diseases
11.2.1. Bacterial Infections
11.2.2. Viral Infections
11.3. Neurological Disorders
11.3.1. Neurodegenerative Disorders
11.3.2. Psychiatric Disorders
11.4. Oncology
11.4.1. Hematological Malignancies
11.4.2. Solid Tumors
11.5. Respiratory Disorders
11.5.1. Asthma
11.5.2. Chronic Obstructive Pulmonary Disease
12. In Vivo CRO Market, by End User
12.1. Academic & Research Institutions
12.2. Government & Regulatory Organizations
12.3. Medical Device Companies
12.4. Pharmaceuticals & Biotechnology Companies
13. In Vivo CRO Market, by Region
13.1. Americas
13.1.1. North America
13.1.2. Latin America
13.2. Europe, Middle East & Africa
13.2.1. Europe
13.2.2. Middle East
13.2.3. Africa
13.3. Asia-Pacific
14. In Vivo CRO Market, by Group
14.1. ASEAN
14.2. GCC
14.3. European Union
14.4. BRICS
14.5. G7
14.6. NATO
15. In Vivo CRO Market, by Country
15.1. United States
15.2. Canada
15.3. Mexico
15.4. Brazil
15.5. United Kingdom
15.6. Germany
15.7. France
15.8. Russia
15.9. Italy
15.10. Spain
15.11. China
15.12. India
15.13. Japan
15.14. Australia
15.15. South Korea
16. United States In Vivo CRO Market
17. China In Vivo CRO Market
18. Competitive Landscape
18.1. Market Concentration Analysis, 2025
18.1.1. Concentration Ratio (CR)
18.1.2. Herfindahl Hirschman Index (HHI)
18.2. Recent Developments & Impact Analysis, 2025
18.3. Product Portfolio Analysis, 2025
18.4. Benchmarking Analysis, 2025
18.5. Altogen Labs
18.6. Biocytogen Boston Corp.
18.7. Cellvax, SAS
18.8. Charles River Laboratories International, Inc.
18.9. Crown Bioscience, Inc.
18.10. Eurofins Scientific SE
18.11. Evotec SE
18.12. Explicyte by Immusmol SAS Company
18.13. GEMPHARMATECH LLC
18.14. ICON Plc
18.15. Imavita S.A.S.
18.16. IQVIA Holdings Inc.
18.17. IVRS AB
18.18. JSR Corporation
18.19. Labcorp Drug Development PRIVATE LIMITED
18.20. Medpace, Inc.
18.21. Melior Discovery Inc.
18.22. Noble Life Sciences Inc.
18.23. Parexel International Corporation
18.24. Pharmacology Discovery Services Ltd.
18.25. Pharmaron Beijing Co., Ltd.
18.26. Pharmatest Services Ltd.
18.27. PPD Inc. by Thermo Fisher Scientific, Inc.
18.28. PSI CRO AG
18.29. Syneos Health Inc.
18.30. Syngene International Limited
18.31. Taconic Biosciences, Inc.
18.32. WuXi AppTec, Inc.
18.33. Yecuris Corporation
List of Figures
FIGURE 1. GLOBAL IN VIVO CRO MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL IN VIVO CRO MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL IN VIVO CRO MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL IN VIVO CRO MARKET SIZE, BY TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL IN VIVO CRO MARKET SIZE, BY SERVICE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL IN VIVO CRO MARKET SIZE, BY MODALITY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL IN VIVO CRO MARKET SIZE, BY INDICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL IN VIVO CRO MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL IN VIVO CRO MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL IN VIVO CRO MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. GLOBAL IN VIVO CRO MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. UNITED STATES IN VIVO CRO MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 13. CHINA IN VIVO CRO MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL IN VIVO CRO MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL IN VIVO CRO MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL IN VIVO CRO MARKET SIZE, BY NON-RODENT, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL IN VIVO CRO MARKET SIZE, BY NON-RODENT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL IN VIVO CRO MARKET SIZE, BY NON-RODENT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL IN VIVO CRO MARKET SIZE, BY RODENT, BY REGION, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL IN VIVO CRO MARKET SIZE, BY RODENT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL IN VIVO CRO MARKET SIZE, BY RODENT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL IN VIVO CRO MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL IN VIVO CRO MARKET SIZE, BY CLINICAL SERVICES, BY REGION, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL IN VIVO CRO MARKET SIZE, BY CLINICAL SERVICES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL IN VIVO CRO MARKET SIZE, BY CLINICAL SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL IN VIVO CRO MARKET SIZE, BY CONSULTING & STRATEGY, BY REGION, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL IN VIVO CRO MARKET SIZE, BY CONSULTING & STRATEGY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL IN VIVO CRO MARKET SIZE, BY CONSULTING & STRATEGY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL IN VIVO CRO MARKET SIZE, BY LABORATORY SERVICES, BY REGION, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL IN VIVO CRO MARKET SIZE, BY LABORATORY SERVICES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL IN VIVO CRO MARKET SIZE, BY LABORATORY SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL IN VIVO CRO MARKET SIZE, BY PRECLINICAL SERVICES, BY REGION, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL IN VIVO CRO MARKET SIZE, BY PRECLINICAL SERVICES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL IN VIVO CRO MARKET SIZE, BY PRECLINICAL SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL IN VIVO CRO MARKET SIZE, BY REGULATORY SERVICES, BY REGION, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL IN VIVO CRO MARKET SIZE, BY REGULATORY SERVICES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL IN VIVO CRO MARKET SIZE, BY REGULATORY SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL IN VIVO CRO MARKET SIZE, BY TOXICOLOGICAL & SAFETY ASSESSMENT, BY REGION, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL IN VIVO CRO MARKET SIZE, BY TOXICOLOGICAL & SAFETY ASSESSMENT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL IN VIVO CRO MARKET SIZE, BY TOXICOLOGICAL & SAFETY ASSESSMENT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL IN VIVO CRO MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL IN VIVO CRO MARKET SIZE, BY LARGE MOLECULES, BY REGION, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL IN VIVO CRO MARKET SIZE, BY LARGE MOLECULES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL IN VIVO CRO MARKET SIZE, BY LARGE MOLECULES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL IN VIVO CRO MARKET SIZE, BY SMALL MOLECULES, BY REGION, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL IN VIVO CRO MARKET SIZE, BY SMALL MOLECULES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL IN VIVO CRO MARKET SIZE, BY SMALL MOLECULES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL IN VIVO CRO MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL IN VIVO CRO MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL IN VIVO CRO MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL IN VIVO CRO MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL IN VIVO CRO MARKET SIZE, BY CARDIOVASCULAR DISEASES, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL IN VIVO CRO MARKET SIZE, BY CORONARY ARTERY DISEASE, BY REGION, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL IN VIVO CRO MARKET SIZE, BY CORONARY ARTERY DISEASE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL IN VIVO CRO MARKET SIZE, BY CORONARY ARTERY DISEASE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL IN VIVO CRO MARKET SIZE, BY HEART FAILURE, BY REGION, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL IN VIVO CRO MARKET SIZE, BY HEART FAILURE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL IN VIVO CRO MARKET SIZE, BY HEART FAILURE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL IN VIVO CRO MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL IN VIVO CRO MARKET SIZE, BY INFECTIOUS DISEASES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL IN VIVO CRO MARKET SIZE, BY INFECTIOUS DISEASES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL IN VIVO CRO MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL IN VIVO CRO MARKET SIZE, BY BACTERIAL INFECTIONS, BY REGION, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL IN VIVO CRO MARKET SIZE, BY BACTERIAL INFECTIONS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL IN VIVO CRO MARKET SIZE, BY BACTERIAL INFECTIONS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL IN VIVO CRO MARKET SIZE, BY VIRAL INFECTIONS, BY REGION, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL IN VIVO CRO MARKET SIZE, BY VIRAL INFECTIONS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL IN VIVO CRO MARKET SIZE, BY VIRAL INFECTIONS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL IN VIVO CRO MARKET SIZE, BY NEUROLOGICAL DISORDERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL IN VIVO CRO MARKET SIZE, BY NEUROLOGICAL DISORDERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL IN VIVO CRO MARKET SIZE, BY NEUROLOGICAL DISORDERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL IN VIVO CRO MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL IN VIVO CRO MARKET SIZE, BY NEURODEGENERATIVE DISORDERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL IN VIVO CRO MARKET SIZE, BY NEURODEGENERATIVE DISORDERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL IN VIVO CRO MARKET SIZE, BY NEURODEGENERATIVE DISORDERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL IN VIVO CRO MARKET SIZE, BY PSYCHIATRIC DISORDERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL IN VIVO CRO MARKET SIZE, BY PSYCHIATRIC DISORDERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL IN VIVO CRO MARKET SIZE, BY PSYCHIATRIC DISORDERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL IN VIVO CRO MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL IN VIVO CRO MARKET SIZE, BY ONCOLOGY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL IN VIVO CRO MARKET SIZE, BY ONCOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL IN VIVO CRO MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL IN VIVO CRO MARKET SIZE, BY HEMATOLOGICAL MALIGNANCIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL IN VIVO CRO MARKET SIZE, BY HEMATOLOGICAL MALIGNANCIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL IN VIVO CRO MARKET SIZE, BY HEMATOLOGICAL MALIGNANCIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL IN VIVO CRO MARKET SIZE, BY SOLID TUMORS, BY REGION, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL IN VIVO CRO MARKET SIZE, BY SOLID TUMORS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL IN VIVO CRO MARKET SIZE, BY SOLID TUMORS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL IN VIVO CRO MARKET SIZE, BY RESPIRATORY DISORDERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL IN VIVO CRO MARKET SIZE, BY RESPIRATORY DISORDERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL IN VIVO CRO MARKET SIZE, BY RESPIRATORY DISORDERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL IN VIVO CRO MARKET SIZE, BY RESPIRATORY DISORDERS, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL IN VIVO CRO MARKET SIZE, BY ASTHMA, BY REGION, 2018-2032 (USD MILLION)
TABLE 81. GLOBAL IN VIVO CRO MARKET SIZE, BY ASTHMA, BY GROUP, 2018-2032 (USD MILLION)
TABLE 82. GLOBAL IN VIVO CRO MARKET SIZE, BY ASTHMA, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 83. GLOBAL IN VIVO CRO MARKET SIZE, BY CHRONIC OBSTRUCTIVE PULMONARY DISEASE, BY REGION, 2018-2032 (USD MILLION)
TABLE 84. GLOBAL IN VIVO CRO MARKET SIZE, BY CHRONIC OBSTRUCTIVE PULMONARY DISEASE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 85. GLOBAL IN VIVO CRO MARKET SIZE, BY CHRONIC OBSTRUCTIVE PULMONARY DISEASE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 86. GLOBAL IN VIVO CRO MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 87. GLOBAL IN VIVO CRO MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTIONS, BY REGION, 2018-2032 (USD MILLION)
TABLE 88. GLOBAL IN VIVO CRO MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTIONS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 89. GLOBAL IN VIVO CRO MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTIONS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 90. GLOBAL IN VIVO CRO MARKET SIZE, BY GOVERNMENT & REGULATORY ORGANIZATIONS, BY REGION, 2018-2032 (USD MILLION)
TABLE 91. GLOBAL IN VIVO CRO MARKET SIZE, BY GOVERNMENT & REGULATORY ORGANIZATIONS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 92. GLOBAL IN VIVO CRO MARKET SIZE, BY GOVERNMENT & REGULATORY ORGANIZATIONS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 93. GLOBAL IN VIVO CRO MARKET SIZE, BY MEDICAL DEVICE COMPANIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 94. GLOBAL IN VIVO CRO MARKET SIZE, BY MEDICAL DEVICE COMPANIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 95. GLOBAL IN VIVO CRO MARKET SIZE, BY MEDICAL DEVICE COMPANIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 96. GLOBAL IN VIVO CRO MARKET SIZE, BY PHARMACEUTICALS & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 97. GLOBAL IN VIVO CRO MARKET SIZE, BY PHARMACEUTICALS & BIOTECHNOLOGY COMPANIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 98. GLOBAL IN VIVO CRO MARKET SIZE, BY PHARMACEUTICALS & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 99. GLOBAL IN VIVO CRO MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 100. AMERICAS IN VIVO CRO MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 101. AMERICAS IN VIVO CRO MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 102. AMERICAS IN VIVO CRO MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
TABLE 103. AMERICAS IN VIVO CRO MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
TABLE 104. AMERICAS IN VIVO CRO MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 105. AMERICAS IN VIVO CRO MARKET SIZE, BY CARDIOVASCULAR DISEASES, 2018-2032 (USD MILLION)
TABLE 106. AMERICAS IN VIVO CRO MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
TABLE 107. AMERICAS IN VIVO CRO MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2032 (USD MILLION)
TABLE 108. AMERICAS IN VIVO CRO MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 109. AMERICAS IN VIVO CRO MARKET SIZE, BY RESPIRATORY DISORDERS, 2018-2032 (USD MILLION)
TABLE 110. AMERICAS IN VIVO CRO MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 111. NORTH AMERICA IN VIVO CRO MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 112. NORTH AMERICA IN VIVO CRO MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 113. NORTH AMERICA IN VIVO CRO MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
TABLE 114. NORTH AMERICA IN VIVO CRO MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
TABLE 115. NORTH AMERICA IN VIVO CRO MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 116. NORTH AMERICA IN VIVO CRO MARKET SIZE, BY CARDIOVASCULAR DISEASES, 2018-2032 (USD MILLION)
TABLE 117. NORTH AMERICA IN VIVO CRO MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
TABLE 118. NORTH AMERICA IN VIVO CRO MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2032 (USD MILLION)
TABLE 119. NORTH AMERICA IN VIVO CRO MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 120. NORTH AMERICA IN VIVO CRO MARKET SIZE, BY RESPIRATORY DISORDERS, 2018-2032 (USD MILLION)
TABLE 121. NORTH AMERICA IN VIVO CRO MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 122. LATIN AMERICA IN VIVO CRO MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 123. LATIN AMERICA IN VIVO CRO MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 124. LATIN AMERICA IN VIVO CRO MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
TABLE 125. LATIN AMERICA IN VIVO CRO MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
TABLE 126. LATIN AMERICA IN VIVO CRO MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 127. LATIN AMERICA IN VIVO CRO MARKET SIZE, BY CARDIOVASCULAR DISEASES, 2018-2032 (USD MILLION)
TABLE 128. LATIN AMERICA IN VIVO CRO MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
TABLE 129. LATIN AMERICA IN VIVO CRO MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2032 (USD MILLION)
TABLE 130. LATIN AMERICA IN VIVO CRO MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 131. LATIN AMERICA IN VIVO CRO MARKET SIZE, BY RESPIRATORY DISORDERS, 2018-2032 (USD MILLION)
TABLE 132. LATIN AMERICA IN VIVO CRO MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 133. EUROPE, MIDDLE EAST & AFRICA IN VIVO CRO MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 134. EUROPE, MIDDLE EAST & AFRICA IN VIVO CRO MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 135. EUROPE, MIDDLE EAST & AFRICA IN VIVO CRO MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
TABLE 136. EUROPE, MIDDLE EAST & AFRICA IN VIVO CRO MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
TABLE 137. EUROPE, MIDDLE EAST & AFRICA IN VIVO CRO MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 138. EUROPE, MIDDLE EAST & AFRICA IN VIVO CRO MARKET SIZE, BY CARDIOVASCULAR DISEASES, 2018-2032 (USD MILLION)
TABLE 139. EUROPE, MIDDLE EAST & AFRICA IN VIVO CRO MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
TABLE 140. EUROPE, MIDDLE EAST & AFRICA IN VIVO CRO MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2032 (USD MILLION)
TABLE 141. EUROPE, MIDDLE EAST & AFRICA IN VIVO CRO MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 142. EUROPE, MIDDLE EAST & AFRICA IN VIVO CRO MARKET SIZE, BY RESPIRATORY DISORDERS, 2018-2032 (USD MILLION)
TABLE 143. EUROPE, MIDDLE EAST & AFRICA IN VIVO CRO MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 144. EUROPE IN VIVO CRO MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 145. EUROPE IN VIVO CRO MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 146. EUROPE IN VIVO CRO MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
TABLE 147. EUROPE IN VIVO CRO MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
TABLE 148. EUROPE IN VIVO CRO MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 149. EUROPE IN VIVO CRO MARKET SIZE, BY CARDIOVASCULAR DISEASES, 2018-2032 (USD MILLION)
TABLE 150. EUROPE IN VIVO CRO MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
TABLE 151. EUROPE IN VIVO CRO MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2032 (USD MILLION)
TABLE 152. EUROPE IN VIVO CRO MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 153. EUROPE IN VIVO CRO MARKET SIZE, BY RESPIRATORY DISORDERS, 2018-2032 (USD MILLION)
TABLE 154. EUROPE IN VIVO CRO MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 155. MIDDLE EAST IN VIVO CRO MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 156. MIDDLE EAST IN VIVO CRO MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 157. MIDDLE EAST IN VIVO CRO MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
TABLE 158. MIDDLE EAST IN VIVO CRO MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
TABLE 159. MIDDLE EAST IN VIVO CRO MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 160. MIDDLE EAST IN VIVO CRO MARKET SIZE, BY CARDIOVASCULAR DISEASES, 2018-2032 (USD MILLION)
TABLE 161. MIDDLE EAST IN VIVO CRO MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
TABLE 162. MIDDLE EAST IN VIVO CRO MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2032 (USD MILLION)
TABLE 163. MIDDLE EAST IN VIVO CRO MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 164. MIDDLE EAST IN VIVO CRO MARKET SIZE, BY RESPIRATORY DISORDERS, 2018-2032 (USD MILLION)
TABLE 165. MIDDLE EAST IN VIVO CRO MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 166. AFRICA IN VIVO CRO MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 167. AFRICA IN VIVO CRO MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 168. AFRICA IN VIVO CRO MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
TABLE 169. AFRICA IN VIVO CRO MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
TABLE 170. AFRICA IN VIVO CRO MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 171. AFRICA IN VIVO CRO MARKET SIZE, BY CARDIOVASCULAR DISEASES, 2018-2032 (USD MILLION)
TABLE 172. AFRICA IN VIVO CRO MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
TABLE 173. AFRICA IN VIVO CRO MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2032 (USD MILLION)
TABLE 174. AFRICA IN VIVO CRO MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 175. AFRICA IN VIVO CRO MARKET SIZE, BY RESPIRATORY DISORDERS, 2018-2032 (USD MILLION)
TABLE 176. AFRICA IN VIVO CRO MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 177. ASIA-PACIFIC IN VIVO CRO MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 178. ASIA-PACIFIC IN VIVO CRO MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 179. ASIA-PACIFIC IN VIVO CRO MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
TABLE 180. ASIA-PACIFIC IN VIVO CRO MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
TABLE 181. ASIA-PACIFIC IN VIVO CRO MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 182. ASIA-PACIFIC IN VIVO CRO MARKET SIZE, BY CARDIOVASCULAR DISEASES, 2018-2032 (USD MILLION)
TABLE 183. ASIA-PACIFIC IN VIVO CRO MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
TABLE 184. ASIA-PACIFIC IN VIVO CRO MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2032 (USD MILLION)
TABLE 185. ASIA-PACIFIC IN VIVO CRO MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 186. ASIA-PACIFIC IN VIVO CRO MARKET SIZE, BY RESPIRATORY DISORDERS, 2018-2032 (USD MILLION)
TABLE 187. ASIA-PACIFIC IN VIVO CRO MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 188. GLOBAL IN VIVO CRO MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 189. ASEAN IN VIVO CRO MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 190. ASEAN IN VIVO CRO MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 191. ASEAN IN VIVO CRO MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
TABLE 192. ASEAN IN VIVO CRO MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
TABLE 193. ASEAN IN VIVO CRO MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 194. ASEAN IN VIVO CRO MARKET SIZE, BY CARDIOVASCULAR DISEASES, 2018-2032 (USD MILLION)
TABLE 195. ASEAN IN VIVO CRO MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
TABLE 196. ASEAN IN VIVO CRO MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2032 (USD MILLION)
TABLE 197. ASEAN IN VIVO CRO MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 198. ASEAN IN VIVO CRO MARKET SIZE, BY RESPIRATORY DISORDERS, 2018-2032 (USD MILLION)
TABLE 199. ASEAN IN VIVO CRO MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 200. GCC IN VIVO CRO MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 201. GCC IN VIVO CRO MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 202. GCC IN VIVO CRO MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
TABLE 203. GCC IN VIVO CRO MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
TABLE 204. GCC IN VIVO CRO MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 205. GCC IN VIVO CRO MARKET SIZE, BY CARDIOVASCULAR DISEASES, 2018-2032 (USD MILLION)
TABLE 206. GCC IN VIVO CRO MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
TABLE 207. GCC IN VIVO CRO MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2032 (USD MILLION)
TABLE 208. GCC IN VIVO CRO MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 209. GCC IN VIVO CRO MARKET SIZE, BY RESPIRATORY DISORDERS, 2018-2032 (USD MILLION)
TABLE 210. GCC IN VIVO CRO MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 211. EUROPEAN UNION IN VIVO CRO MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 212. EUROPEAN UNION IN VIVO CRO MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 213. EUROPEAN UNION IN VIVO CRO MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
TABLE 214. EUROPEAN UNION IN VIVO CRO MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
TABLE 215. EUROPEAN UNION IN VIVO CRO MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 216. EUROPEAN UNION IN VIVO CRO MARKET SIZE, BY CARDIOVASCULAR DISEASES, 2018-2032 (USD MILLION)
TABLE 217. EUROPEAN UNION IN VIVO CRO MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
TABLE 218. EUROPEAN UNION IN VIVO CRO MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2032 (USD MILLION)
TABLE 219. EUROPEAN UNION IN VIVO CRO MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 220. EUROPEAN UNION IN VIVO CRO MARKET SIZE, BY RESPIRATORY DISORDERS, 2018-2032 (USD MILLION)
TABLE 221. EUROPEAN UNION IN VIVO CRO MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 222. BRICS IN VIVO CRO MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 223. BRICS IN VIVO CRO MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 224. BRICS IN VIVO CRO MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
TABLE 225. BRICS IN VIVO CRO MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
TABLE 226. BRICS IN VIVO CRO MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 227. BRICS IN VIVO CRO MARKET SIZE, BY CARDIOVASCULAR DISEASES, 2018-2032 (USD MILLION)
TABLE 228. BRICS IN VIVO CRO MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
TABLE 229. BRICS IN VIVO CRO MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2032 (USD MILLION)
TABLE 230. BRICS IN VIVO CRO MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 231. BRICS IN VIVO CRO MARKET SIZE, BY RESPIRATORY DISORDERS, 2018-2032 (USD MILLION)
TABLE 232. BRICS IN VIVO CRO MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 233. G7 IN VIVO CRO MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 234. G7 IN VIVO CRO MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 235. G7 IN VIVO CRO MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
TABLE 236. G7 IN VIVO CRO MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
TABLE 237. G7 IN VIVO CRO MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 238. G7 IN VIVO CRO MARKET SIZE, BY CARDIOVASCULAR DISEASES, 2018-2032 (USD MILLION)
TABLE 239. G7 IN VIVO CRO MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
TABLE 240. G7 IN VIVO CRO MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2032 (USD MILLION)
TABLE 241. G7 IN VIVO CRO MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 242. G7 IN VIVO CRO MARKET SIZE, BY RESPIRATORY DISORDERS, 2018-2032 (USD MILLION)
TABLE 243. G7 IN VIVO CRO MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 244. NATO IN VIVO CRO MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 245. NATO IN VIVO CRO MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 246. NATO IN VIVO CRO MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
TABLE 247. NATO IN VIVO CRO MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
TABLE 248. NATO IN VIVO CRO MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 249. NATO IN VIVO CRO MARKET SIZE, BY CARDIOVASCULAR DISEASES, 2018-2032 (USD MILLION)
TABLE 250. NATO IN VIVO CRO MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
TABLE 251. NATO IN VIVO CRO MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2032 (USD MILLION)
TABLE 252. NATO IN VIVO CRO MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 253. NATO IN VIVO CRO MARKET SIZE, BY RESPIRATORY DISORDERS, 2018-2032 (USD MILLION)
TABLE 254. NATO IN VIVO CRO MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 255. GLOBAL IN VIVO CRO MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 256. UNITED STATES IN VIVO CRO MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 257. UNITED STATES IN VIVO CRO MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 258. UNITED STATES IN VIVO CRO MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
TABLE 259. UNITED STATES IN VIVO CRO MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
TABLE 260. UNITED STATES IN VIVO CRO MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 261. UNITED STATES IN VIVO CRO MARKET SIZE, BY CARDIOVASCULAR DISEASES, 2018-2032 (USD MILLION)
TABLE 262. UNITED STATES IN VIVO CRO MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
TABLE 263. UNITED STATES IN VIVO CRO MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2032 (USD MILLION)
TABLE 264. UNITED STATES IN VIVO CRO MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 265. UNITED STATES IN VIVO CRO MARKET SIZE, BY RESPIRATORY DISORDERS, 2018-2032 (USD MILLION)
TABLE 266. UNITED STATES IN VIVO CRO MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 267. CHINA IN VIVO CRO MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 268. CHINA IN VIVO CRO MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 269. CHINA IN VIVO CRO MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
TABLE 270. CHINA IN VIVO CRO MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
TABLE 271. CHINA IN VIVO CRO MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 272. CHINA IN VIVO CRO MARKET SIZE, BY CARDIOVASCULAR DISEASES, 2018-2032 (USD MILLION)
TABLE 273. CHINA IN VIVO CRO MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
TABLE 274. CHINA IN VIVO CRO MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2032 (USD MILLION)
TABLE 275. CHINA IN VIVO CRO MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 276. CHINA IN VIVO CRO MARKET SIZE, BY RESPIRATORY DISORDERS, 2018-2032 (USD MILLION)
TABLE 277. CHINA IN VIVO CRO MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)

Companies Mentioned

The key companies profiled in this In Vivo CRO market report include:
  • Altogen Labs
  • Biocytogen Boston Corp.
  • Cellvax, SAS
  • Charles River Laboratories International, Inc.
  • Crown Bioscience, Inc.
  • Eurofins Scientific SE
  • Evotec SE
  • Explicyte by Immusmol SAS Company
  • GEMPHARMATECH LLC
  • ICON Plc
  • Imavita S.A.S.
  • IQVIA Holdings Inc.
  • IVRS AB
  • JSR Corporation
  • Labcorp Drug Development PRIVATE LIMITED
  • Medpace, Inc.
  • Melior Discovery Inc.
  • Noble Life Sciences Inc.
  • Parexel International Corporation
  • Pharmacology Discovery Services Ltd.
  • Pharmaron Beijing Co., Ltd.
  • Pharmatest Services Ltd.
  • PPD Inc. by Thermo Fisher Scientific, Inc.
  • PSI CRO AG
  • Syneos Health Inc.
  • Syngene International Limited
  • Taconic Biosciences, Inc.
  • WuXi AppTec, Inc.
  • Yecuris Corporation

Table Information

Report AttributeDetails
No. of Pages192
PublishedJanuary 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 7.21 Billion
Forecasted Market Value ( USD ) by 2032 $ 12.88 Billion
Compound Annual Growth Rate10.0%
Regions CoveredGlobal
No. of Companies Mentioned30

Related Topics

Related Reports

In Vivo Contract Research Organization (CRO) - Global Strategic Business Report - Product Image

In Vivo Contract Research Organization (CRO) - Global Strategic Business Report

  • Report
  • 220 Pages
  • Global
From
In-Vivo CRO Market - Global Strategic Business Report - Product Image

In-Vivo CRO Market - Global Strategic Business Report

  • Report
  • 387 Pages
  • Global
From
Oncology Based In-Vivo CRO Market - Global Forecast 2026-2032 - Product Image

Oncology Based In-Vivo CRO Market - Global Forecast 2026-2032

  • Report
  • 184 Pages
  • Global
From
In-vivo CRO Market Report by Type, GLP Type, Indication, and Region 2025-2033 - Product Image

In-vivo CRO Market Report by Type, GLP Type, Indication, and Region 2025-2033

  • Report
  • 146 Pages
  • Global
From
Oncology Based In-Vivo CRO Market Report and Forecast 2025-2034 - Product Image

Oncology Based In-Vivo CRO Market Report and Forecast 2025-2034

  • Report
  • 350 Pages
  • Global
From

About the In Vivo CRO Market

The In Vivo CRO market is a subset of the biotechnology industry that focuses on providing contract research services to pharmaceutical and biotechnology companies. These services include preclinical and clinical trials, drug development, and regulatory affairs. In Vivo CRO companies provide expertise in areas such as pharmacology, toxicology, and clinical research. They also provide services such as data management, biostatistics, and medical writing. In Vivo CRO companies are typically small to medium-sized businesses that specialize in a particular area of research. They are often located in countries with a strong biotechnology industry, such as the United States, Canada, and Europe. Some companies in the In Vivo CRO market include Charles River Laboratories, Covance, Parexel, and Quintiles. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.